BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baylis C. Arginine, arginine analogs and nitric oxide production in chronic kidney disease. Nat Clin Pract Nephrol. 2006;2:209-220. [PMID: 16932427 DOI: 10.1038/ncpneph0143] [Cited by in Crossref: 144] [Cited by in F6Publishing: 136] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Shelite TR, Liang Y, Wang H, Mendell NL, Trent BJ, Sun J, Gong B, Xu G, Hu H, Bouyer DH, Soong L. IL-33-Dependent Endothelial Activation Contributes to Apoptosis and Renal Injury in Orientia tsutsugamushi-Infected Mice. PLoS Negl Trop Dis 2016;10:e0004467. [PMID: 26943125 DOI: 10.1371/journal.pntd.0004467] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
2 Bahlmann F, Kielstein J, Haller H, Fliser D. Erythropoietin and progression of CKD. Kidney International 2007;72:S21-5. [DOI: 10.1038/sj.ki.5002484] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
3 Jourde-Chiche N, Dou L, Cerini C, Dignat-George F, Brunet P. Vascular incompetence in dialysis patients--protein-bound uremic toxins and endothelial dysfunction. Semin Dial. 2011;24:327-337. [PMID: 21682773 DOI: 10.1111/j.1525-139x.2011.00925.x] [Cited by in Crossref: 117] [Cited by in F6Publishing: 60] [Article Influence: 10.6] [Reference Citation Analysis]
4 Tain YL, Freshour G, Dikalova A, Griendling K, Baylis C. Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5/6 nephrectomized rat. Am J Physiol Renal Physiol 2007;292:F1404-10. [PMID: 17200156 DOI: 10.1152/ajprenal.00260.2006] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 4.2] [Reference Citation Analysis]
5 Paroni R, Barassi A, Ciociola F, Dozio E, Finati E, Fermo I, Ghilardi F, Colpi GM, Corsi MM, Melzi d’Eril GV. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L-arginine in patients with arteriogenic and non-arteriogenic erectile dysfunction: ADMA and SDMA in erectile dysfunction. International Journal of Andrology 2012;35:660-7. [DOI: 10.1111/j.1365-2605.2012.01272.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
6 Sandqvist A, Schneede J, Kylhammar D, Henrohn D, Lundgren J, Hedeland M, Bondesson U, Rådegran G, Wikström G. Plasma L-arginine levels distinguish pulmonary arterial hypertension from left ventricular systolic dysfunction. Heart Vessels 2018;33:255-63. [PMID: 28975394 DOI: 10.1007/s00380-017-1055-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
7 Teerlink T, Luo Z, Palm F, Wilcox CS. Cellular ADMA: regulation and action. Pharmacol Res 2009;60:448-60. [PMID: 19682580 DOI: 10.1016/j.phrs.2009.08.002] [Cited by in Crossref: 164] [Cited by in F6Publishing: 151] [Article Influence: 12.6] [Reference Citation Analysis]
8 Huang J, Ladeiras D, Yu Y, Ming XF, Yang Z. Detrimental Effects of Chronic L-Arginine Rich Food on Aging Kidney. Front Pharmacol 2020;11:582155. [PMID: 33542686 DOI: 10.3389/fphar.2020.582155] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Dupont JJ, Farquhar WB, Townsend RR, Edwards DG. Ascorbic acid or L-arginine improves cutaneous microvascular function in chronic kidney disease. J Appl Physiol. 2011;111:1561-1567. [PMID: 21885796 DOI: 10.1152/japplphysiol.00419.2011] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
10 Kovács A, Szabó L, Longstaff C, Tenekedjiev K, Machovich R, Kolev K. Ambivalent roles of carboxypeptidase B in the lytic susceptibility of fibrin. Thromb Res 2014;133:80-7. [PMID: 24094605 DOI: 10.1016/j.thromres.2013.09.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
11 Yang T, Zhou Y, Cheong S, Kong C, Mazur F, Liang K, Chandrawati R. Modulating nitric oxide-generating activity of zinc oxide by morphology control and surface modification. Mater Sci Eng C Mater Biol Appl 2021;130:112428. [PMID: 34702513 DOI: 10.1016/j.msec.2021.112428] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tain YL, Muller V, Szabo AJ, Erdely A, Smith C, Baylis C. Renal cortex neuronal nitric oxide synthase in response to rapamycin in kidney transplantation. Nitric Oxide 2008;18:80-6. [PMID: 17971307 DOI: 10.1016/j.niox.2007.10.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
13 Roumeliotis S, Mallamaci F, Zoccali C. Endothelial Dysfunction in Chronic Kidney Disease, from Biology to Clinical Outcomes: A 2020 Update. J Clin Med 2020;9:E2359. [PMID: 32718053 DOI: 10.3390/jcm9082359] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 13.5] [Reference Citation Analysis]
14 Kooman JP, Stenvinkel P, Shiels PG, Feelisch M, Canaud B, Kotanko P. The oxygen cascade in patients treated with hemodialysis and native high-altitude dwellers: lessons from extreme physiology to benefit patients with end-stage renal disease. Am J Physiol Renal Physiol 2021;320:F249-61. [PMID: 33356957 DOI: 10.1152/ajprenal.00540.2020] [Reference Citation Analysis]
15 Landsberg A, Sharma A, Gibson IW, Rush D, Wishart DS, Blydt-hansen TD. Non-invasive staging of chronic kidney allograft damage using urine metabolomic profiling. Pediatr Transplantation 2018;22:e13226. [DOI: 10.1111/petr.13226] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
16 Carlström M. Nitric oxide signalling in kidney regulation and cardiometabolic health. Nat Rev Nephrol 2021;17:575-90. [PMID: 34075241 DOI: 10.1038/s41581-021-00429-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Martens CR, Edwards DG. Peripheral vascular dysfunction in chronic kidney disease. Cardiol Res Pract 2011;2011:267257. [PMID: 21637718 DOI: 10.4061/2011/267257] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
18 Avci B, Alacam H, Dilek A, Kozan A. Effects of asymmetric dimethylarginine on inflammatory cytokines (TNF- α , IL-6 and IL-10) in rats. Toxicol Ind Health 2015;31:268-73. [DOI: 10.1177/0748233712472524] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
19 Costa MR, Ponciano VC, Costa TR, de Oliveira AM, Gomes CP, de Oliveira EC. Prevalence and factors associated with erectile dysfunction in patients with chronic kidney disease on conservative treatment. Int J Impot Res 2017;29:219-24. [DOI: 10.1038/ijir.2017.20] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
20 Newsholme P, Homem De Bittencourt PI, O' Hagan C, De Vito G, Murphy C, Krause MS. Exercise and possible molecular mechanisms of protection from vascular disease and diabetes: the central role of ROS and nitric oxide. Clin Sci (Lond) 2009;118:341-9. [PMID: 19922417 DOI: 10.1042/CS20090433] [Cited by in Crossref: 63] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
21 Mirmiran P, Bahadoran Z, Ghasemi A, Azizi F. The Association of Dietary l-Arginine Intake and Serum Nitric Oxide Metabolites in Adults: A Population-Based Study. Nutrients 2016;8:E311. [PMID: 27213443 DOI: 10.3390/nu8050311] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
22 Zhou Q, Chen S, Li H, Yang B, Chen T, Hu T, Yin D, He H, He M. Tetramethylpyrazine alleviates iron overload damage in vascular endothelium via upregulating DDAHII expression. Toxicol In Vitro 2020;65:104817. [PMID: 32135237 DOI: 10.1016/j.tiv.2020.104817] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Baylis C. Nitric oxide synthase derangements and hypertension in kidney disease. Curr Opin Nephrol Hypertens 2012;21:1-6. [PMID: 22048724 DOI: 10.1097/MNH.0b013e32834d54ca] [Cited by in Crossref: 84] [Cited by in F6Publishing: 40] [Article Influence: 8.4] [Reference Citation Analysis]
24 Rhee EP. A Systems-Level View of Renal Metabolomics. Semin Nephrol 2018;38:142-50. [PMID: 29602397 DOI: 10.1016/j.semnephrol.2018.01.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
25 Tain YL, Ghosh S, Krieg RJ, Baylis C. Reciprocal changes of renal neuronal nitric oxide synthase-α and -β associated with renal progression in a neonatal 5/6 nephrectomized rat model. Pediatr Neonatol 2011;52:66-72. [PMID: 21524625 DOI: 10.1016/j.pedneo.2011.02.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
26 Ozkurt S, Sahin G, Degirmenci N, Temiz G, Musmul A, Tek M, Birdane A, Tekin N, Akyuz F, Yalcin A. Late Effects of Renal Transplantation on Endothelial Functions and Cardiac Morphology. Transplantation Proceedings 2011;43:2606-11. [DOI: 10.1016/j.transproceed.2011.06.042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
27 Speranza L, Franceschelli S, D'orazio N, Gaeta R, Bucciarelli T, Felaco M, Grilli A, Riccioni G. The biological effect of pharmacological treatment on dimethylaminohydrolases (DDAH-1) and cationic amino acid transporter-1 (CAT-1) expression in patients with acute congestive heart failure. Microvascular Research 2011;82:391-6. [DOI: 10.1016/j.mvr.2011.06.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
28 Bahlmann FH, Fliser D. Erythropoietin and renoprotection. Curr Opin Nephrol Hypertens 2009;18:15-20. [PMID: 19077684 DOI: 10.1097/MNH.0b013e32831a9dde] [Cited by in Crossref: 53] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
29 Girndt M, Seibert E. Premature cardiovascular disease in chronic renal failure (CRF): A model for an advanced ageing process. Experimental Gerontology 2010;45:797-800. [DOI: 10.1016/j.exger.2010.04.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
30 Serman Y, Fuentealba RA, Pasten C, Rocco J, Ko BCB, Carrión F, Irarrázabal CE. Emerging new role of NFAT5 in inducible nitric oxide synthase in response to hypoxia in mouse embryonic fibroblast cells. American Journal of Physiology-Cell Physiology 2019;317:C31-8. [DOI: 10.1152/ajpcell.00054.2019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Ling XC, Kuo K. Oxidative stress in chronic kidney disease. Ren Replace Ther 2018;4. [DOI: 10.1186/s41100-018-0195-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 8] [Article Influence: 8.8] [Reference Citation Analysis]
32 Williams JK, Smallwood MJ, Benjamin N, D'Souza RJ, Shore AC, Winyard PG, Gilchrist M. Renal nitrate clearance in chronic kidney disease. Nitric Oxide 2020;97:16-9. [PMID: 32007629 DOI: 10.1016/j.niox.2020.01.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
33 Bonanni A, Mannucci I, Verzola D, Sofia A, Saffioti S, Gianetta E, Garibotto G. Protein-energy wasting and mortality in chronic kidney disease. Int J Environ Res Public Health 2011;8:1631-54. [PMID: 21655142 DOI: 10.3390/ijerph8051631] [Cited by in Crossref: 64] [Cited by in F6Publishing: 52] [Article Influence: 5.8] [Reference Citation Analysis]
34 Nowak KL, Chonchol M, Ikizler TA, Farmer-Bailey H, Salas N, Chaudhry R, Wang W, Smits G, Tengesdal I, Dinarello CA, Hung AM. IL-1 Inhibition and Vascular Function in CKD. J Am Soc Nephrol 2017;28:971-80. [PMID: 27647856 DOI: 10.1681/ASN.2016040453] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
35 Hutchens MP, De Miguel C. The CAT-1 is out of the bag: endothelial Cationic Amino Acid Transporter-1 is a critical player in cardiorenal syndrome type 2. Clin Sci (Lond) 2021;135:105-8. [PMID: 33404050 DOI: 10.1042/CS20201319] [Reference Citation Analysis]
36 De Fatima Cavanal M, Gomes GN, Forti AL, Rocha SO, Franco MDCP, Fortes ZB, Gil FZ. The Influence of L-Arginine on Blood Pressure, Vascular Nitric Oxide and Renal Morphometry in the Offspring from Diabetic Mothers. Pediatr Res 2007;62:145-50. [DOI: 10.1203/pdr.0b013e318098722e] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
37 Yang T, Zelikin AN, Chandrawati R. Enzyme Mimics for the Catalytic Generation of Nitric Oxide from Endogenous Prodrugs. Small 2020;16:1907635. [DOI: 10.1002/smll.201907635] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
38 Wu-Wong JR, Noonan W, Nakane M, Brooks KA, Segreti JA, Polakowski JS, Cox B. Vitamin d receptor activation mitigates the impact of uremia on endothelial function in the 5/6 nephrectomized rats. Int J Endocrinol 2010;2010:625852. [PMID: 20169119 DOI: 10.1155/2010/625852] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
39 Vasdev S, Gill V. The antihypertensive effect of arginine. Int J Angiol 2008;17:7-22. [PMID: 22477366 DOI: 10.1055/s-0031-1278274] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
40 Pillai SM, Seebeck P, Fingerhut R, Huang J, Ming XF, Yang Z, Verrey F. Kidney Mass Reduction Leads to l-Arginine Metabolism-Dependent Blood Pressure Increase in Mice. J Am Heart Assoc 2018;7:e008025. [PMID: 29478971 DOI: 10.1161/JAHA.117.008025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
41 Singh RR, Easton LK, Booth LC, Schlaich MP, Head GA, Moritz KM, Denton KM. Renal Nitric Oxide Deficiency and Chronic Kidney Disease in Young Sheep Born with a Solitary Functioning Kidney. Sci Rep 2016;6:26777. [PMID: 27226113 DOI: 10.1038/srep26777] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
42 Popolo A, Adesso S, Pinto A, Autore G, Marzocco S. L-Arginine and its metabolites in kidney and cardiovascular disease. Amino Acids 2014;46:2271-86. [PMID: 25161088 DOI: 10.1007/s00726-014-1825-9] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 6.4] [Reference Citation Analysis]
43 Xue H, Geurts AM, Usa K, Wang F, Lin Y, Phillips J, Henderson L, Baker MA, Tian Z, Liang M. Fumarase Overexpression Abolishes Hypertension Attributable to endothelial NO synthase Haploinsufficiency in Dahl Salt-Sensitive Rats. Hypertension 2019;74:313-22. [PMID: 31230549 DOI: 10.1161/HYPERTENSIONAHA.119.12723] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
44 Lamas S, Rodríguez-Puyol D. Endothelial control of vasomotor tone: the kidney perspective. Semin Nephrol 2012;32:156-66. [PMID: 22617764 DOI: 10.1016/j.semnephrol.2012.02.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
45 Amador-martínez I, Pérez-villalva R, Uribe N, Cortés-gonzález C, Bobadilla NA, Barrera-chimal J. Reduced endothelial nitric oxide synthase activation contributes to cardiovascular injury during chronic kidney disease progression. American Journal of Physiology-Renal Physiology 2019;317:F275-85. [DOI: 10.1152/ajprenal.00020.2019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
46 Jarajapu YP, Grant MB. The promise of cell-based therapies for diabetic complications: challenges and solutions. Circ Res. 2010;106:854-869. [PMID: 20299675 DOI: 10.1161/circresaha.109.213140] [Cited by in Crossref: 98] [Cited by in F6Publishing: 62] [Article Influence: 8.2] [Reference Citation Analysis]
47 Tektaş AK, Uslu S, Yalçin AU, Sahin G, Temiz G, Kara M, Temel HE, Demirkan ES, Colak E, Colak O. Effects of lipoprotein-associated phospholipase A2 on arginase/nitric oxide pathway in hemodialysis patients. Ren Fail 2012;34:738-43. [PMID: 22583316 DOI: 10.3109/0886022X.2012.681535] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
48 Tain Y, Hsieh C, Lin I, Chen C, Sheen J, Huang L. Effects of maternal l-citrulline supplementation on renal function and blood pressure in offspring exposed to maternal caloric restriction: The impact of nitric oxide pathway. Nitric Oxide 2010;23:34-41. [DOI: 10.1016/j.niox.2010.03.005] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 5.3] [Reference Citation Analysis]
49 Souza MK, Moraes MR, Rosa TS, Passos CS, Neves RVP, Haro AS, Cenedeze MA, Arias SCA, Fujihara CK, Teixeira SA, Muscará MN, Câmara NOS, Pacheco E Silva Filho A. l-Arginine supplementation blunts resistance exercise improvement in rats with chronic kidney disease. Life Sci 2019;232:116604. [PMID: 31260684 DOI: 10.1016/j.lfs.2019.116604] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
50 Wang D, Strandgaard S, Borresen ML, Luo Z, Connors SG, Yan Q, Wilcox CS. Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney disease. Am J Kidney Dis 2008;51:184-91. [PMID: 18215696 DOI: 10.1053/j.ajkd.2007.09.020] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 3.3] [Reference Citation Analysis]
51 Zapolski T, Wysokiński A, Książek A, Jaroszyński A. Left atrial volume index and aortic stiffness index in adult hemodialysed patients--link between compliance and pressure mediated by endothelium dysfunction; a cross-sectional study. BMC Cardiovasc Disord 2012;12:100. [PMID: 23122326 DOI: 10.1186/1471-2261-12-100] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
52 Tain YL, Huang LT, Hsu CN, Lee CT. Melatonin therapy prevents programmed hypertension and nitric oxide deficiency in offspring exposed to maternal caloric restriction. Oxid Med Cell Longev 2014;2014:283180. [PMID: 24864188 DOI: 10.1155/2014/283180] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
53 Tessari P, Cecchet D, Cosma A, Vettore M, Coracina A, Millioni R, Iori E, Puricelli L, Avogaro A, Vedovato M. Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy. Diabetes 2010;59:2152-9. [PMID: 20484137 DOI: 10.2337/db09-1772] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 7.1] [Reference Citation Analysis]
54 Staab EB, Weigel J, Xiao F, Madayiputhiya N, Wyatt TA, Wells SM. Asymmetric dimethyl-arginine metabolism in a murine model of cigarette smoke-mediated lung inflammation. J Immunotoxicol 2015;12:273-82. [PMID: 25913572 DOI: 10.3109/1547691X.2014.961619] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
55 Mallamaci F, Benedetto FA, Tripepi G, Cutrupi S, Pizzini P, Stancanelli B, Seminara G, Bonanno G, Rapisarda F, Fatuzzo P, Malatino LS, Zoccali C. Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients. J Hypertens 2008;26:1875-82. [PMID: 18698224 DOI: 10.1097/HJH.0b013e328307c3d2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
56 Mathew AV, Zeng L, Byun J, Pennathur S. Metabolomic Profiling of Arginine Metabolome Links Altered Methylation to Chronic Kidney Disease Accelerated Atherosclerosis. J Proteomics Bioinform 2015;Suppl 14:001. [PMID: 26778898 DOI: 10.4172/jpb.S14-001] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
57 Cheng M, Wu T, Huang L, Tain Y. Renoprotective Effects of Melatonin in Young Spontaneously Hypertensive Rats with L-NAME. Pediatrics & Neonatology 2014;55:189-95. [DOI: 10.1016/j.pedneo.2013.09.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
58 Xiao M, Zheng L, Zhang X, Duan X, Hang T, Lu S, Liu S, Lin H. Renal-on-Chip Microfluidic Platform with a Force-Sensitive Resistor (ROC-FS) for Molecular Pathogenesis Analysis of Hydronephrosis. Anal Chem 2021. [PMID: 34951537 DOI: 10.1021/acs.analchem.1c03155] [Reference Citation Analysis]
59 Sheen JM, Chen YC, Tain YL, Huang LT. Increased circulatory asymmetric dimethylarginine and multiple organ failure: bile duct ligation in rat as a model. Int J Mol Sci. 2014;15:3989-4006. [PMID: 24603538 DOI: 10.3390/ijms15033989] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
60 Chen GF, Moningka NC, Sasser JM, Zharikov S, Cunningham M Jr, Tain YL, Schwartz IF, Baylis C. Arginine and asymmetric dimethylarginine in puromycin aminonucleoside-induced chronic kidney disease in the rat. Am J Nephrol 2012;35:40-8. [PMID: 22179117 DOI: 10.1159/000334740] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
61 Palm F, Onozato ML, Luo Z, Wilcox CS. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol. 2007;293:H3227-H3245. [PMID: 17933965 DOI: 10.1152/ajpheart.00998.2007] [Cited by in Crossref: 222] [Cited by in F6Publishing: 207] [Article Influence: 14.8] [Reference Citation Analysis]
62 Hu H, Qian K, Ho MC, Zheng YG. Small Molecule Inhibitors of Protein Arginine Methyltransferases. Expert Opin Investig Drugs 2016;25:335-58. [PMID: 26789238 DOI: 10.1517/13543784.2016.1144747] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 11.0] [Reference Citation Analysis]
63 Ciuntu A. Role of Metabolites of Nitric Oxide and Arginase in the Pathogenesis of Glomerulonephritis. Curr Health Sci J 2016;42:221-5. [PMID: 30581575 DOI: 10.12865/CHSJ.42.03.01] [Reference Citation Analysis]
64 Aldámiz-Echevarría L, Andrade F. Asymmetric dimethylarginine, endothelial dysfunction and renal disease. Int J Mol Sci 2012;13:11288-311. [PMID: 23109853 DOI: 10.3390/ijms130911288] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
65 Kruse NT. Nutraceuticals as a potential adjunct therapy toward improving vascular health in CKD. Am J Physiol Regul Integr Comp Physiol 2019;317:R719-32. [PMID: 31577157 DOI: 10.1152/ajpregu.00152.2019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
66 Wilcox CS. Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables. Hypertension 2012;59:375-81. [PMID: 22215715 DOI: 10.1161/HYPERTENSIONAHA.111.187310] [Cited by in Crossref: 60] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
67 Günthner T, Jankowski V, Kretschmer A, Nierhaus M, van der Giet M, Zidek W, Jankowski J. Endothelium and Vascular Smooth Muscle Cells in the Context of Uremia. Seminars in Dialysis 2009;22:428-32. [DOI: 10.1111/j.1525-139x.2009.00594.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
68 Heunisch F, Chaykovska L, von Einem G, Alter M, Dschietzig T, Kretschmer A, Kellner KH, Hocher B. ADMA predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus undergoing coronary angiography. Medicine (Baltimore) 2017;96:e6065. [PMID: 28178159 DOI: 10.1097/MD.0000000000006065] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
69 Burger D, Touyz RM. Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells. J Am Soc Hypertens. 2012;6:85-99. [PMID: 22321962 DOI: 10.1016/j.jash.2011.11.003] [Cited by in Crossref: 129] [Cited by in F6Publishing: 117] [Article Influence: 12.9] [Reference Citation Analysis]
70 McCann Haworth SM, Zhuge Z, Nihlén C, Von Rosen MF, Weitzberg E, Lundberg JO, Krmar RT, Nasiell J, Carlström M. Red blood cells from patients with pre-eclampsia induce endothelial dysfunction. J Hypertens 2021;39:1628-41. [PMID: 33657586 DOI: 10.1097/HJH.0000000000002834] [Reference Citation Analysis]
71 Sztanek F, Seres I, Harangi M, Lőcsey L, Padra J, Paragh GJ, Asztalos L, Paragh G. Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease. Nephrol Dial Transplant 2012;27:2866-72. [PMID: 22247228 DOI: 10.1093/ndt/gfr753] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
72 Underwood CF, Hildreth CM, Wyse BF, Boyd R, Goodchild AK, Phillips JK. Uraemia: an unrecognized driver of central neurohumoral dysfunction in chronic kidney disease? Acta Physiol (Oxf) 2017;219:305-23. [PMID: 27247097 DOI: 10.1111/apha.12727] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
73 Schwartz IF, Grupper A, Soetendorp H, Hillel O, Laron I, Chernichovski T, Ingbir M, Shtabski A, Weinstein T, Chernin G, Shashar M, Hershkoviz R, Schwartz D. Attenuated glomerular arginine transport prevents hyperfiltration and induces HIF-1α in the pregnant uremic rat. Am J Physiol Renal Physiol 2012;303:F396-404. [PMID: 22552935 DOI: 10.1152/ajprenal.00488.2011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
74 Kirkman DL, Ramick MG, Muth BJ, Stock JM, Pohlig RT, Townsend RR, Edwards DG. Effects of aerobic exercise on vascular function in nondialysis chronic kidney disease: a randomized controlled trial. Am J Physiol Renal Physiol 2019;316:F898-905. [PMID: 30810061 DOI: 10.1152/ajprenal.00539.2018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
75 Jabarpour M, Rashtchizadeh N, Argani H, Ghorbanihaghjo A, Ranjbarzadhag M, Sanajou D, Panah F, Alirezaei A. The impact of dyslipidemia and oxidative stress on vasoactive mediators in patients with renal dysfunction. Int Urol Nephrol 2019;51:2235-42. [DOI: 10.1007/s11255-019-02319-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
76 Ambarkar M, Pemmaraju SV, Gouroju S, Manohar SM, Bitla AR, Yajamanam N, Vishnubhotla S. Adipokines and their Relation to Endothelial Dysfunction in Patients with Chronic Kidney Disease. J Clin Diagn Res 2016;10:BC04-8. [PMID: 26894055 DOI: 10.7860/JCDR/2016/15867.7060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
77 Buijs N, Brinkmann SJ, Oosterink JE, Luttikhold J, Schierbeek H, Wisselink W, Beishuizen A, van Goudoever JB, Houdijk AP, van Leeuwen PA, Vermeulen MA. Intravenous glutamine supplementation enhances renal de novo arginine synthesis in humans: a stable isotope study. The American Journal of Clinical Nutrition 2014;100:1385-91. [DOI: 10.3945/ajcn.113.081547] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
78 Chang KA, Lin IC, Sheen JM, Chen YC, Chen CC, Tain YL, Hsieh CS, Huang LT. Sex differences of oxidative stress to cholestatic liver and kidney injury in young rats. Pediatr Neonatol. 2013;54:95-101. [PMID: 23590953 DOI: 10.1016/j.pedneo.2012.11.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
79 Segal MS, Baylis C, Johnson RJ. Endothelial health and diversity in the kidney. J Am Soc Nephrol 2006;17:323-4. [PMID: 16434502 DOI: 10.1681/ASN.2005121296] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
80 Amoah BY, Asare GA, Yeboah FA, Obirikorang C, Asiedu B, Mohammed AO. Biomarkers of renal dysfunction among Ghanaian patients with type 2 diabetes mellitus- a cross-sectional study. Int J Diabetes Dev Ctries 2018;38:437-44. [DOI: 10.1007/s13410-018-0615-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Marin E, Sessa WC. Role of endothelial-derived nitric oxide in hypertension and renal disease: . Current Opinion in Nephrology and Hypertension 2007;16:105-10. [DOI: 10.1097/mnh.0b013e328017f893] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
82 Baylis C. Sexual dimorphism of the aging kidney: role of nitric oxide deficiency. Physiology (Bethesda) 2008;23:142-50. [PMID: 18556467 DOI: 10.1152/physiol.00001.2008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
83 Burmakin M, Fasching A, Kobayashi H, Urrutia AA, Damdimopoulos A, Palm F, Haase VH. Pharmacological HIF-PHD inhibition reduces renovascular resistance and increases glomerular filtration by stimulating nitric oxide generation. Acta Physiol (Oxf) 2021;233:e13668. [PMID: 33900001 DOI: 10.1111/apha.13668] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
84 Shelkovnikov S, Summers SM, Elahimehr R, Adams G, Purdy RE, Vaziri ND. Effect of exercise training on aortic tone in chronic renal insufficiency. Am J Hypertens 2008;21:564-9. [PMID: 18437148 DOI: 10.1038/ajh.2008.24] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
85 Yalçınkaya Yavuz Ö, Aydoğdu N, Taştekin E, Süt N. The Effects of Baicalin on Myoglobinuric Acute Renal Failure in Rats. Balkan Med J 2018;35:68-76. [PMID: 28903885 DOI: 10.4274/balkanmedj.2017.0040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
86 Garibotto G, Sofia A, Saffioti S, Bonanni A, Mannucci I, Verzola D. Amino acid and protein metabolism in the human kidney and in patients with chronic kidney disease. Clin Nutr 2010;29:424-33. [PMID: 20207454 DOI: 10.1016/j.clnu.2010.02.005] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 4.4] [Reference Citation Analysis]
87 Assis RP, Castro JF, Gutierres VO, Arcaro CA, Brotto RS, Oliveira OM, Baviera AM, Brunetti IL. Effects of uremic solutes on reactive oxygen species in vitro model systems as a possibility of support the renal function management. BMC Nephrol 2015;16:50. [PMID: 25886160 DOI: 10.1186/s12882-015-0029-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
88 Boykin JV Jr, Baylis C. Hyperbaric oxygen therapy mediates increased nitric oxide production associated with wound healing: a preliminary study. Adv Skin Wound Care 2007;20:382-8. [PMID: 17620739 DOI: 10.1097/01.ASW.0000280198.81130.d5] [Cited by in Crossref: 56] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
89 Linden E, Cai W, He JC, Xue C, Li Z, Winston J, Vlassara H, Uribarri J. Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation. Clin J Am Soc Nephrol 2008;3:691-8. [PMID: 18256374 DOI: 10.2215/CJN.04291007] [Cited by in Crossref: 101] [Cited by in F6Publishing: 51] [Article Influence: 7.2] [Reference Citation Analysis]
90 Kalantari S, Nafar M, Samavat S, Parvin M, Nobakht M Gh BF, Barzi F. 1 H NMR-based metabolomics exploring urinary biomarkers correlated with proteinuria in focal segmental glomerulosclerosis: a pilot study. Magn Reson Chem 2016;54:821-6. [PMID: 27320161 DOI: 10.1002/mrc.4460] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
91 Kalantari S, Nafar M. An update of urine and blood metabolomics in chronic kidney disease. Biomarkers in Medicine 2019;13:577-96. [DOI: 10.2217/bmm-2019-0008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
92 Zaric BL, Radovanovic JN, Gluvic Z, Stewart AJ, Essack M, Motwalli O, Gojobori T, Isenovic ER. Atherosclerosis Linked to Aberrant Amino Acid Metabolism and Immunosuppressive Amino Acid Catabolizing Enzymes. Front Immunol 2020;11:551758. [PMID: 33117340 DOI: 10.3389/fimmu.2020.551758] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
93 Li J, Wilson A, Gao X, Kuruba R, Liu Y, Poloyac S, Pitt B, Xie W, Li S. Coordinated regulation of dimethylarginine dimethylaminohydrolase-1 and cationic amino acid transporter-1 by farnesoid X receptor in mouse liver and kidney and its implication in the control of blood levels of asymmetric dimethylarginine. J Pharmacol Exp Ther 2009;331:234-43. [PMID: 19605523 DOI: 10.1124/jpet.109.153510] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
94 Martens CR, Kirkman DL, Edwards DG. The Vascular Endothelium in Chronic Kidney Disease: A Novel Target for Aerobic Exercise. Exerc Sport Sci Rev 2016;44:12-9. [PMID: 26509484 DOI: 10.1249/JES.0000000000000065] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
95 Małgorzewicz S, Dębska-ślizień A, Rutkowski B, Łysiak-szydłowska W. Serum Concentration of Amino Acids Versus Nutritional Status in Hemodialysis Patients. Journal of Renal Nutrition 2008;18:239-47. [DOI: 10.1053/j.jrn.2007.11.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
96 Schrader H, Menge BA, Belyaev O, Uhl W, Schmidt WE, Meier JJ. Amino acid malnutrition in patients with chronic pancreatitis and pancreatic carcinoma. Pancreas. 2009;38:416-421. [PMID: 19169171 DOI: 10.1097/mpa.0b013e318194fc7a] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
97 Ahmad A, Riaz Z, Sattar MA, Khan SA, John EJ, Rashid S, Shah STA, Rafiq MA, Azam M, Qamar R. Effect of gasotransmitters treatment on expression of hypertension, vascular and cardiac remodeling and hypertensive nephropathy genes in left ventricular hypertrophy. Gene 2020;737:144479. [PMID: 32068124 DOI: 10.1016/j.gene.2020.144479] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
98 Reddy YS, Kiranmayi VS, Bitla AR, Krishna GS, Rao PV, Sivakumar V. Nitric oxide status in patients with chronic kidney disease. Indian J Nephrol 2015;25:287-91. [PMID: 26628794 DOI: 10.4103/0971-4065.147376] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
99 Vanella L, Canestraro M, Lee CR, Cao J, Zeldin DC, Schwartzman ML, Abraham NG. Soluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasis. Prostaglandins Other Lipid Mediat 2015;120:139-47. [PMID: 25908301 DOI: 10.1016/j.prostaglandins.2015.04.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
100 Bouteldja N, Woodman RJ, Hewitson CL, Domingo E, Barbara JA, Mangoni AA. Methylated arginines and nitric oxide in end-stage renal disease: impact of inflammation, oxidative stress and haemodialysis. Biomarkers 2013;18:357-64. [PMID: 23672496 DOI: 10.3109/1354750X.2013.795608] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
101 Pang P, Abbott M, Abdi M, Fucci QA, Chauhan N, Mistri M, Proctor B, Chin M, Wang B, Yin W, Lu TS, Halim A, Lim K, Handy DE, Loscalzo J, Siedlecki AM. Pre-clinical model of severe glutathione peroxidase-3 deficiency and chronic kidney disease results in coronary artery thrombosis and depressed left ventricular function. Nephrol Dial Transplant 2018;33:923-34. [PMID: 29244159 DOI: 10.1093/ndt/gfx304] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
102 Musso CG, Jauregui JR, Macías Núñez JF. Frailty phenotype and chronic kidney disease: a review of the literature. Int Urol Nephrol 2015;47:1801-7. [DOI: 10.1007/s11255-015-1112-z] [Cited by in Crossref: 55] [Cited by in F6Publishing: 37] [Article Influence: 7.9] [Reference Citation Analysis]
103 Heller A, Westphal SE, Bartsch P, Haase M, Mertens PR. Chronic kidney disease is associated with high abdominal incisional hernia rates and wound healing disturbances. Int Urol Nephrol 2014;46:1175-81. [DOI: 10.1007/s11255-013-0565-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
104 Abedini S, Meinitzer A, Holme I, März W, Weihrauch G, Fellstrøm B, Jardine A, Holdaas H. Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients. Kidney Int. 2010;77:44-50. [PMID: 19847152 DOI: 10.1038/ki.2009.382] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
105 You Z, Xin Y, Liu Y, Han B, Zhang L, Chen Y, Chen Y, Gu L, Gao H, Xuan Y. Protective effect of Salvia Miltiorrhizae injection on N(G)-nitro-d-arginine induced nitric oxide deficient and oxidative damage in rat kidney. Experimental and Toxicologic Pathology 2012;64:453-8. [DOI: 10.1016/j.etp.2010.10.013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
106 Kanbay M, Yilmaz MI, Sonmez A, Turgut F, Saglam M, Cakir E, Yenicesu M, Covic A, Jalal D, Johnson RJ. Serum uric acid level and endothelial dysfunction in patients with nondiabetic chronic kidney disease. Am J Nephrol 2011;33:298-304. [PMID: 21389694 DOI: 10.1159/000324847] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 6.2] [Reference Citation Analysis]
107 Wang T, Zhang Y, Niu K, Wang L, Shi Y, Liu B. Association of the -449GC and -1151AC polymorphisms in the DDAH2 gene with asymmetric dimethylarginine and erythropoietin resistance in Chinese patients on maintenance hemodialysis. Clin Exp Pharmacol Physiol. 2017;44:961-964. [PMID: 28590543 DOI: 10.1111/1440-1681.12793] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
108 Brown KE, Dhaun N, Goddard J, Webb DJ. Potential Therapeutic Role of Phosphodiesterase Type 5 Inhibition in Hypertension and Chronic Kidney Disease. Hypertension 2014;63:5-11. [DOI: 10.1161/hypertensionaha.113.01774] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
109 Toyohara T, Suzuki T, Morimoto R, Akiyama Y, Souma T, Shiwaku HO, Takeuchi Y, Mishima E, Abe M, Tanemoto M, Masuda S, Kawano H, Maemura K, Nakayama M, Sato H, Mikkaichi T, Yamaguchi H, Fukui S, Fukumoto Y, Shimokawa H, Inui K, Terasaki T, Goto J, Ito S, Hishinuma T, Rubera I, Tauc M, Fujii-Kuriyama Y, Yabuuchi H, Moriyama Y, Soga T, Abe T. SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation. J Am Soc Nephrol 2009;20:2546-55. [PMID: 19875811 DOI: 10.1681/ASN.2009070696] [Cited by in Crossref: 90] [Cited by in F6Publishing: 35] [Article Influence: 6.9] [Reference Citation Analysis]
110 Wagner L, Laczy B, Tamaskó M, Mazák I, Markó L, Molnár GA, Wagner Z, Mohás M, Cseh J, Fekete A. Cigarette smoke-induced alterations in endothelial nitric oxide synthase phosphorylation: role of protein kinase C. Endothelium. 2007;14:245-255. [PMID: 17922342 DOI: 10.1080/10623320701606707] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
111 Giuggioli D, Colaci M, Sebastiani M, Ferri C. L-Arginine in pregnant scleroderma patients. Clin Rheumatol 2010;29:937-9. [PMID: 20213128 DOI: 10.1007/s10067-010-1396-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
112 D'Elia RV, Goodchild SA, Winder CL, Southam AD, Weber RJM, Stahl FM, Docx C, Patel V, Green AC, Viant MR, Lukaszewski RA, Dunn WB. Multiple metabolic pathways are predictive of ricin intoxication in a rat model. Metabolomics 2019;15:102. [PMID: 31270703 DOI: 10.1007/s11306-019-1547-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
113 Haruna Y, Kashihara N, Satoh M, Tomita N, Namikoshi T, Sasaki T, Fujimori T, Xie P, Kanwar YS. Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proc Natl Acad Sci U S A 2007;104:2331-6. [PMID: 17287345 DOI: 10.1073/pnas.0611079104] [Cited by in Crossref: 166] [Cited by in F6Publishing: 157] [Article Influence: 11.1] [Reference Citation Analysis]
114 González-peña D, Dudzik D, Colina-coca C, de Ancos B, García A, Barbas C, Sánchez-moreno C. Multiplatform metabolomic fingerprinting as a tool for understanding hypercholesterolemia in Wistar rats. Eur J Nutr 2016;55:997-1010. [DOI: 10.1007/s00394-015-0914-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
115 Zinellu A, Sotgia S, Mangoni AA, Sotgiu E, Ena S, Satta AE, Carru C. Effect of cholesterol lowering treatment on plasma markers of endothelial dysfunction in chronic kidney disease. Journal of Pharmaceutical and Biomedical Analysis 2016;129:383-8. [DOI: 10.1016/j.jpba.2016.07.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
116 Hsu C, Huang L, Lau Y, Lin C, Tain Y. The combined ratios of L-arginine and asymmetric and symmetric dimethylarginine as biomarkers in spontaneously hypertensive rats. Translational Research 2012;159:90-8. [DOI: 10.1016/j.trsl.2011.09.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
117 Bai Y, Sigala W, Adams GR, Vaziri ND. Effect of exercise on cardiac tissue oxidative and inflammatory mediators in chronic kidney disease. Am J Nephrol 2009;29:213-21. [PMID: 18797164 DOI: 10.1159/000156715] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
118 Tain YL, Lee WC, Hsu CN, Lee WC, Huang LT, Lee CT, Lin CY. Asymmetric dimethylarginine is associated with developmental programming of adult kidney disease and hypertension in offspring of streptozotocin-treated mothers. PLoS One 2013;8:e55420. [PMID: 23408977 DOI: 10.1371/journal.pone.0055420] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 5.4] [Reference Citation Analysis]
119 Bonnet J, Sultan A. Narrative Review of the Relationship Between CKD and Diabetic Foot Ulcer. Kidney International Reports 2021. [DOI: 10.1016/j.ekir.2021.12.018] [Reference Citation Analysis]
120 Zheng X, Zhou L, Jin Y, Zhao X, Ahmad H, OuYang Y, Chen S, Du J, Chen X, Chen L, Gao D, Yang Z, Tian Z. β-Aminoisobutyric acid supplementation attenuated salt-sensitive hypertension in Dahl salt-sensitive rats through prevention of insufficient fumarase. Amino Acids 2021. [PMID: 34837556 DOI: 10.1007/s00726-021-03092-7] [Reference Citation Analysis]
121 Lee JH, Park GH, Lee YK, Park JH. Changes in the arginine methylation of organ proteins during the development of diabetes mellitus. Diabetes Research and Clinical Practice 2011;94:111-8. [DOI: 10.1016/j.diabres.2011.07.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
122 Lankadeva YR, Singh RR, Tare M, Moritz KM, Denton KM. Loss of a kidney during fetal life: long-term consequences and lessons learned. Am J Physiol Renal Physiol 2014;306:F791-800. [PMID: 24500691 DOI: 10.1152/ajprenal.00666.2013] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
123 Papadopoulou E, Varouktsi A, Lazaridis A, Boutari C, Doumas M. Erectile dysfunction in chronic kidney disease: From pathophysiology to management. World J Nephrol 2015; 4(3): 379-387 [PMID: 26167462 DOI: 10.5527/wjn.v4.i3.379] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
124 Sasser JM, Akinsiku O, Moningka NC, Jerzewski K, Baylis C, LeBlanc AJ, Kang LS, Sindler AL, Muller-Delp JM. Sexual dimorphism in development of kidney damage in aging Fischer-344 rats. Gend Med 2012;9:219-31. [PMID: 22819558 DOI: 10.1016/j.genm.2012.06.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
125 Fulton MD, Brown T, Zheng YG. Mechanisms and Inhibitors of Histone Arginine Methylation. Chem Rec 2018;18:1792-807. [PMID: 30230223 DOI: 10.1002/tcr.201800082] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
126 Targher G, Bosworth C, Kendrick J, Smits G, Lippi G, Chonchol M. Relationship of serum bilirubin concentrations to kidney function and albuminuria in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001-2006. Clin Chem Lab Med. 2009;47:1055-1062. [PMID: 19634983 DOI: 10.1515/cclm.2009.244] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
127 Raptis V, Kapoulas S, Grekas D. Role of asymmetrical dimethylarginine in the progression of renal disease. Nephrology (Carlton). 2013;18:11-21. [PMID: 23016674 DOI: 10.1111/j.1440-1797.2012.01659.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
128 Tain Y, Huang L. Asymmetric Dimethylarginine: Clinical Applications in Pediatric Medicine. Journal of the Formosan Medical Association 2011;110:70-7. [DOI: 10.1016/s0929-6646(11)60012-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 16] [Article Influence: 3.9] [Reference Citation Analysis]
129 Vera-Aviles M, Vantana E, Kardinasari E, Koh NL, Latunde-Dada GO. Protective Role of Histidine Supplementation Against Oxidative Stress Damage in the Management of Anemia of Chronic Kidney Disease. Pharmaceuticals (Basel) 2018;11:E111. [PMID: 30347874 DOI: 10.3390/ph11040111] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
130 Singh P, Deng A, Weir MR, Blantz RC. The balance of angiotensin II and nitric oxide in kidney diseases. Current Opinion in Nephrology & Hypertension 2008;17:51-6. [DOI: 10.1097/mnh.0b013e3282f29a8b] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
131 Carlström M, Brown RD, Edlund J, Sällström J, Larsson E, Teerlink T, Palm F, Wåhlin N, Persson AEG. Role of nitric oxide deficiency in the development of hypertension in hydronephrotic animals. American Journal of Physiology-Renal Physiology 2008;294:F362-70. [DOI: 10.1152/ajprenal.00410.2007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
132 Palm F, Nordquist L, Wilcox CS, Hansell P. Oxidative Stress and Hypoxia in the Pathogenesis of Diabetic Nephropathy. In: Miyata T, Eckardt K, Nangaku M, editors. Studies on Renal Disorders. Totowa: Humana Press; 2011. pp. 559-86. [DOI: 10.1007/978-1-60761-857-7_29] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
133 Heredia Martinez A, Rosa Diez G, Ferraris V, Coccia PA, Ferraris JR, Checa A, Wheelock CE, Lundberg JO, Weitzberg E, Carlström M, Krmar RT. "Removal of nitrate and nitrite by hemodialysis in end-stage renal disease and by sustained low-efficiency dialysis in acute kidney injury". Nitric Oxide 2020;98:33-40. [PMID: 32119993 DOI: 10.1016/j.niox.2020.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
134 Qiu J, Cheng J, Xie Y, Jiang L, Shi P, Li X, Swanda RV, Zhou J, Wang Y. 1,4-Dioxane exposure induces kidney damage in mice by perturbing specific renal metabolic pathways: An integrated omics insight into the underlying mechanisms. Chemosphere 2019;228:149-58. [DOI: 10.1016/j.chemosphere.2019.04.111] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
135 Bai Y, Hui R. Dimethylarginine dimethylaminohydrolase (DDAH) – A critical regulator of hypertensive left ventricular hypertrophy? Medical Hypotheses 2008;70:962-6. [DOI: 10.1016/j.mehy.2007.08.028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
136 Bugnicourt J, Silveira CD, Bengrine A, Godefroy O, Baumbach G, Sevestre H, Bode-boeger SM, Kielstein JT, Massy ZA, Chillon J. Chronic renal failure alters endothelial function in cerebral circulation in mice. American Journal of Physiology-Heart and Circulatory Physiology 2011;301:H1143-52. [DOI: 10.1152/ajpheart.01237.2010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
137 Defeudis G, Mazzilli R, Tenuta M, Rossini G, Zamponi V, Olana S, Faggiano A, Pozzilli P, Isidori AM, Gianfrilli D. Erectile dysfunction and diabetes: A melting pot of circumstances and treatments. Diabetes Metab Res Rev 2021;:e3494. [PMID: 34514697 DOI: 10.1002/dmrr.3494] [Reference Citation Analysis]
138 Moradi H, Kwok V, Vaziri ND. Effect of chronic renal failure on arginase and argininosuccinate synthetase expression. Am J Nephrol 2006;26:310-8. [PMID: 16809898 DOI: 10.1159/000094344] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
139 Davani-Davari D, Karimzadeh I, Sagheb MM, Khalili H. The Renal Safety of L-Carnitine, L-Arginine, and Glutamine in Athletes and Bodybuilders. J Ren Nutr 2019;29:221-34. [PMID: 30341034 DOI: 10.1053/j.jrn.2018.08.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
140 Carlström M, Brown RD, Yang T, Hezel M, Larsson E, Scheffer PG, Teerlink T, Lundberg JO, Persson AE. L-arginine or tempol supplementation improves renal and cardiovascular function in rats with reduced renal mass and chronic high salt intake. Acta Physiol (Oxf) 2013;207:732-41. [PMID: 23387940 DOI: 10.1111/apha.12079] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
141 Syme H. Hypertension in small animal kidney disease. Vet Clin North Am Small Anim Pract 2011;41:63-89. [PMID: 21251511 DOI: 10.1016/j.cvsm.2010.11.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
142 Lai EY, Luo Z, Onozato ML, Rudolph EH, Solis G, Jose PA, Wellstein A, Aslam S, Quinn MT, Griendling K. Effects of the antioxidant drug tempol on renal oxygenation in mice with reduced renal mass. Am J Physiol Renal Physiol. 2012;303:F64-F74. [PMID: 22492941 DOI: 10.1152/ajprenal.00005.2012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]